Ann Lab Med.  2024 Jan;44(1):3-5. 10.3343/alm.2024.44.1.3.

New Insights Into SARS-CoV-2-specific Antibody Levels in Kidney Transplantation Recipients After Three Vaccination Doses

• Kang H
• Oh EJ

• KMID: 2550210
• DOI: http://doi.org/10.3343/alm.2024.44.1.3

Keyword

Antibody; Breakthrough infection; Cut-off; Humoral immunity; Kidney transplantation; SARS-CoV-2; Titer

Reference

1. Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M. 2020; COVID-19 infection in kidney transplant recipients. Kidney Int. 97:1076–82. DOI: 10.1016/j.kint.2020.03.018. PMID: 32354637. PMCID: PMC7142878.

2. Seo YJ, Oh I, Nam M, Shin S, Roh EY, Song EY. 2023; Comparison of four T-cell assays and two binding antibody assays in SARS-CoV-2 vaccinees with or without Omicron breakthrough infection. Ann Lab Med. 43:596–604. DOI: 10.3343/alm.2023.43.6.596. PMID: 37387492. PMCID: PMC10345181.

3. Lee A, Wong SY, Chai LYA, Lee SC, Lee MX, Muthiah MD, et al. 2022; Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis. BMJ. 376:e068632. DOI: 10.1136/bmj-2021-068632. PMID: 35236664. PMCID: PMC8889026.

4. Kim J-A, Bang HI, Shin JW, Park Y, Kim S, Kim M-Y, et al. 2022; Immunogenicity of third-dose BNT162b2 mRNA vaccine following two doses of ChAdOx1 in health care workers: a prospective longitudinal study. Ann Lab Med. 42:688–92. DOI: 10.3343/alm.2022.42.6.688. PMID: 35765878. PMCID: PMC9277035.

5. Lioulios G, Fylaktou A, Asouchidou D, Xochelli A, Nikolaidou V, Stai S, et al. 2023; Effect of lymphocyte phenotypic alterations on the humoral response to vaccination against SARS-COV-2 in dialysis patients. Ann Lab Med. 43:451–60. DOI: 10.3343/alm.2023.43.5.451. PMID: 37080746. PMCID: PMC10151274.

6. Feng S, Phillips DJ, White T, Sayal H, Aley PK, Bibi S, et al. 2021; Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nat Med. 27:2032–40. DOI: 10.1038/s41591-021-01540-1. PMID: 34588689. PMCID: PMC8604724.

7. Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, et al. 2021; Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 27:1205–11. DOI: 10.1038/s41591-021-01377-8. PMID: 34002089.

8. Plume J, Galvanovskis A, Smite S, Romanchikova N, Zayakin P, Line A. 2022; Early and strong antibody responses to SARS-CoV-2 predict disease severity in COVID-19 patients. J Transl Med. 20:176. DOI: 10.1186/s12967-022-03382-y. PMID: 35428263. PMCID: PMC9012069.

9. Choi S-H, Park JY, Park JH, Kim M-C, Kweon OJ, Chung J-W. 2022; Investigation of the neutralizing antibody response of healthcare workers at a Korean University hospital six months after the introduction of the COVID-19 vaccine. Ann Lab Med. 42:612–5. DOI: 10.3343/alm.2022.42.5.612. PMID: 35470282. PMCID: PMC9057825.

10. Yun S, Ryu JH, Jang JH, Bae H, Yoo S-H, Choi A-R, et al. 2021; Comparison of SARS-CoV-2 antibody responses and seroconversion in COVID-19 patients using twelve commercial immunoassays. Ann Lab Med. 41:577–87. DOI: 10.3343/alm.2021.41.6.577. PMID: 34108285. PMCID: PMC8203431.

11. Kemlin D, Gemander N, Depickere S, Olislagers V, Georges D, Waegemans A, et al. 2023; Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients. Am J Transplant. 23:649–58. DOI: 10.1016/j.ajt.2023.02.015. PMID: 36773936. PMCID: PMC9911984.

12. Lammert A, Schnuelle P, Rabenau HF, Ciesek S, Kramer BK, Gottmann U, et al. 2022; SARS-CoV-2 vaccination in kidney transplant recipients-stratified analysis of the humoral immune response. Transplant Direct. 8:e1384. DOI: 10.1097/TXD.0000000000001384. PMID: 36259077. PMCID: PMC9575732.

13. Wolfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Muller MA, et al. 2020; Virological assessment of hospitalized patients with COVID-2019. Nature. 581:465–9. DOI: 10.1038/s41586-020-2196-x. PMID: 32235945.

14. Alejo JL, Chiang TPY, Bowles Zeiser L, Kim JD, Mitchell J, Avery RK, et al. 2022; Incidence and severity of COVID-19 among vaccinated solid organ transplant recipients during the Omicron wave. Transplantation. 106:e413–e5. DOI: 10.1097/TP.0000000000004226. PMID: 35655363.

15. Bertrand D, Laurent C, Lemee V, Lebourg L, Hanoy M, Le Roy F, et al. 2022; Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients. Kidney Int. 102:440–2. DOI: 10.1016/j.kint.2022.05.007. PMID: 35618097. PMCID: PMC9125992.

16. Bonazzetti C, Tazza B, Gibertoni D, Pasquini Z, Caroccia N, Fani F, et al. 2023; Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: the CONTRAST Cohort. Clin Infect Dis. 76:1761–7. DOI: 10.1093/cid/ciad016. PMID: 36636955. PMCID: PMC10209432.

17. Rodriguez-Cubillo B, Moreno de la Higuera MA, Perez-Flores I, Calvo Romero N, Aiffil AS, Arribi Vilela A, et al. 2022; Clinical effectiveness of SARS-CoV-2 vaccination in renal transplant recipients. antibody levels impact in pneumonia and death. Transplantation. 106:e476–e87. DOI: 10.1097/TP.0000000000004261. PMID: 35859270.

18. Han A, Min S, Jo EA, Lee H, Kim YC, Han SS, et al. 2024; Association between low anti-spike antibody levels after the thrid dose SARS-CoV-2 vaccination and hospitalization from symptomatic breakthrough infection in kidney transplant recipients. Ann Lab Med. 44:64–73. DOI: 10.3343/alm.2024.44.1.64. PMID: 37665287.